Stocks and Investing Stocks and Investing
Tue, November 8, 2022
[ 12:00 AM ] - WOPRAI
Jason English Maintained (WW) at Hold with Decreased Target to $3.8 on, Nov 8th, 2022
[ 12:00 AM ] - WOPRAI
Anthony Pettinari Maintained (SUM) at Strong Buy with Increased Target to $32 on, Nov 8th, 2022
[ 12:00 AM ] - WOPRAI
Landon Park Maintained (VSAT) at Hold with Increased Target to $36 on, Nov 8th, 2022
[ 12:00 AM ] - WOPRAI
Nik Cremo Maintained (VRRM) at Buy with Decreased Target to $18 on, Nov 8th, 2022
[ 12:00 AM ] - WOPRAI
Toni Kaplan Initiated (VRSK) at Hold and Held Target at $170 on, Nov 8th, 2022
[ 12:00 AM ] - WOPRAI
Tyler Batory Maintained (VVI) at Buy with Decreased Target to $42 on, Nov 8th, 2022
[ 12:00 AM ] - WOPRAI
David Amsellem Upgraded (VTRS) to Hold and Held Target at $10 on, Nov 8th, 2022
Mon, November 7, 2022
[ 12:00 AM ] - WOPRAI
Sean Lee Maintained (VSTM) at Strong Buy with Decreased Target to $36 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Steven Valiquette Maintained (VTR) at Buy with Decreased Target to $57 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Steve Sakwa Maintained (VTR) at Hold with Decreased Target to $45 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
C. Gregory Peters Maintained (VRSK) at Buy with Decreased Target to $185 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
John Ivankoe Maintained (SYY) at Buy with Decreased Target to $86 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Gabriel Moreen Maintained (SUN) at Strong Buy with Increased Target to $48 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Ramsey El-Assal Maintained (WU) at Sell with Decreased Target to $11 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Linda Bolton Weiser Maintained (WW) at Strong Buy with Decreased Target to $6 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Kaumil Gajrawala Maintained (YETI) at Buy with Decreased Target to $60 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Gary Nachman Maintained (TEVA) at Hold with Decreased Target to $10 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Ric Prentiss Downgraded (TDS) to Hold on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Fatima Boolani Maintained (TEAM) at Strong Buy with Decreased Target to $210 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Josh Beck Maintained (BIGC) at Buy with Decreased Target to $15 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Gabriela Borges Maintained (BIGC) at Strong Buy with Decreased Target to $23 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Mike Dahl Maintained (BECN) at Hold with Decreased Target to $54 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Jonathan Reeder Maintained (BEPC) at Buy with Decreased Target to $37 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Jonathan Reeder Maintained (BEP) at Buy with Decreased Target to $35 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Mani Foroohar Maintained (BEAM) at Buy with Decreased Target to $81 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Raghuram Selvaraju Maintained (BCPC) at Strong Buy with Decreased Target to $152 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Swayampakula Ramakanth Maintained (CDXS) at Stron .. uy with Decreased Target to $15 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
PJ Juvekar Maintained (CE) at Hold with Decreased Target to $96 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Kevin Steinke Maintained (CCRN) at Buy with Increased Target to $45 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Mark Massaro Maintained (CDNA) at Strong Buy with Decreased Target to $28 on, Nov 7th, 2022

Mark Massaro Maintained (CDNA) at Strong Buy with Decreased Target to $28 on, Nov 7th, 2022


Published on 2024-10-27 23:59:44 - WOPRAI, Mark Massaro
  Print publication without navigation


Mark Massaro of BTIG, Maintained "CareDx, Inc" (CDNA) at Strong Buy with Decreased Target from $37 to $28 on, Nov 7th, 2022.

Mark has made no other calls on CDNA in the last 4 months.



There are 2 other peers that have a rating on CDNA. Out of the 2 peers that are also analyzing CDNA, 0 agree with Mark's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Mark

  • Matthew Sykes of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $40 on, Friday, November 4th, 2022
  • Andrew Cooper of "Raymond James" Maintained at Strong Buy with Decreased Target to $35 on, Wednesday, August 10th, 2022
Contributing Sources